(Reuters) - Additional data from the studies indicated that the the
drug, Riquent, was well tolerated even at high doses, Chief
Executive Deirdre Gillespie said in a statement.
Riquent, unlike other lupus drugs, does not suppress the
immune system that can result in serious infections, he said.
Read more at Reuters.com Government Filings News
drug, Riquent, was well tolerated even at high doses, Chief
Executive Deirdre Gillespie said in a statement.
Riquent, unlike other lupus drugs, does not suppress the
immune system that can result in serious infections, he said.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment